KIEV, March 18 – India's Dr.Reddy's integrated international pharmaceutical company is still optimistic about the Ukrainian pharmaceutical market and continues developing its Ukrainian business, Dr.Reddy's Executive Vice President M.V. Ramana has said.

"Ukraine is a key market that Dr.Reddy's is focusing on," he told Interfax-Ukraine.

Commenting on the company’s operation in Ukraine in 2015, Ramana said that the economic turmoil has had a direct impact on the company's business. General slow on the Ukrainian pharmaceutical market and a decline in buying power have made a serious gap in the company's efficiency.